Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113883.3.1444.3.212 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.212/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.212 |
Version | 20230622 |
Status | active |
Date | 2023-06-22T01:00:59-04:00 |
Name | BRCA1AndBRCA2Testing |
Title | BRCA1 and BRCA2 Testing |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA1 and BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA1 and BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA1 and BRCA2 by Immune Stain.) |
No resources found
CodeSystem | |
cpt | Current Procedural Terminology (CPT®) |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113883.3.1444.3.212", "meta": { "versionId": "6", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "American Society of Clinical Oncology Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-07-03" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2023-06-22" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.212", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.3.1444.3.212" } ], "version": "20230622", "name": "BRCA1AndBRCA2Testing", "title": "BRCA1 and BRCA2 Testing", "status": "active", "date": "2023-06-22T01:00:59-04:00", "publisher": "American Society of Clinical Oncology Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA1 and BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA1 and BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA1 and BRCA2 by Immune Stain.)", "compose": { "include": [ { "system": "http://www.ama-assn.org/go/cpt", "concept": [ { "code": "81162", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)" }, { "code": "81163", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis" }, { "code": "81164", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)" }, { "code": "81212", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variants" } ] } ] }, "expansion": { "identifier": "urn:uuid:f48239a9-22b0-4d0d-acbf-249f196829ea", "timestamp": "2025-05-23T21:54:57-04:00", "total": 4, "contains": [ { "system": "http://www.ama-assn.org/go/cpt", "version": "2025", "code": "81162", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)" }, { "system": "http://www.ama-assn.org/go/cpt", "version": "2025", "code": "81163", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis" }, { "system": "http://www.ama-assn.org/go/cpt", "version": "2025", "code": "81164", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)" }, { "system": "http://www.ama-assn.org/go/cpt", "version": "2025", "code": "81212", "display": "BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variants" } ] } }